What is Galmed Pharmaceuticals Ltd (GLMD) stock price today?

Galmed Pharmaceuticals Ltd (GLMD) currently trades at $0.56 per share. The stock has a market capitalization of $4.12M and a P/E ratio of —x.

Is GLMD stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Galmed Pharmaceuticals Ltd has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is —.

Is Galmed Pharmaceuticals Ltd financially healthy?

Galmed Pharmaceuticals Ltd's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of — places it in the —.

GLMD

Galmed Pharmaceuticals Ltd

NASDAQ: GLMD · HEALTHCARE · BIOTECHNOLOGY

$0.56

-4.92% today

Updated 2026-04-29

Market cap

$4.12M

P/E ratio

—

P/S ratio

61.38x

EPS (TTM)

$-2.39

Dividend yield

—

52W range

$0 – $2

Volume

3.7M

Market cap

$4.12M

P/E ratio

—

P/S ratio

61.38x

EPS (TTM)

$-2.39

Dividend yield

—

52W range

$0 – $2

Volume

3.7M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$12.00

+2042.47%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-1.95M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-17.87M	$-6.91M	$-7.52M	$-10.31M	$-4.82M
EPS	—	—	—	—	$-2.39
Free cash flow	$-18.50M	$-6.14M	$-5.88M	$-6.32M	$-1.95M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GLMD	$4.12M	26	4.3	3.0	5.0	6.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Galmed Pharmaceuticals Ltd trades at $0.56. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is Galmed Pharmaceuticals Ltd's stock price?

Galmed Pharmaceuticals Ltd (GLMD) trades at $0.56.

Is Galmed Pharmaceuticals Ltd overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of Galmed Pharmaceuticals Ltd (GLMD)?

The analyst target price is $12.00, representing +2042.5% upside from the current price of $0.56.

Piotroski F-Score?

2/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

galmedpharma.com

Quick metrics

P/S ratio61.38x

ROE-64.20%

Beta0.47

50D MA$0.62

200D MA$1.09

Shares out0.01B

Float0.01B

Short ratio—

Avg volume3.7M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GLMD vs LLY →GLMD vs JNJ →GLMD vs ABBV →Stock screener →